Reilly Financial Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,071
Closed -$106K 969
2019
Q3
$106K Buy
1,071
+325
+44% +$30.9K 0.01% 243
2019
Q2
$69K Sell
746
-62
-8% -$5.89K 0.01% 306
2019
Q1
$76K Sell
808
-59
-7% -$5.16K 0.01% 278
2018
Q4
$56K Sell
867
-185
-18% -$13.7K 0.01% 311
2018
Q3
$94K Hold
1,052
0.01% 252
2018
Q2
$84K Sell
1,052
-250
-19% -$20.8K 0.01% 240
2018
Q1
$116K Sell
1,302
-268
-17% -$25.7K 0.02% 204
2017
Q4
$164K Sell
1,570
-332
-17% -$37.5K 0.02% 181
2017
Q3
$277K Buy
1,902
+56
+3% +$7.63K 0.04% 133
2017
Q2
$240K Buy
1,846
+635
+52% +$77.8K 0.04% 147
2017
Q1
$151K Buy
1,211
+161
+15% +$19.3K 0.02% 165
2016
Q4
$122K Buy
1,050
+256
+32% +$28.5K 0.02% 176
2016
Q3
$83K Buy
794
+40
+5% +$4.33K 0.01% 214
2016
Q2
$74K Hold
754
0.01% 217
2016
Q1
$75K Buy
754
+50
+7% +$5.15K 0.01% 316
2015
Q4
$84K Sell
704
-15
-2% -$1.74K 0.01% 299
2015
Q3
$78K Sell
719
-52
-7% -$6.45K 0.01% 298
2015
Q2
$89K Sell
771
-348
-31% -$39.8K 0.02% 307
2015
Q1
$129K Buy
1,119
+440
+65% +$52.6K 0.02% 225
2014
Q4
$76K Buy
679
+244
+56% +$25.7K 0.02% 216
2014
Q3
$41K Buy
435
+265
+156% +$23.9K 0.01% 281
2014
Q2
$15K Buy
170
+50
+42% +$3.8K ﹤0.01% 474
2014
Q1
$8K Sell
120
-214
-64% -$16.9K ﹤0.01% 608
2013
Q4
$28K Buy
334
+88
+36% +$6.96K 0.01% 338
2013
Q3
$19K Sell
246
-100
-29% -$7.01K 0.01% 365
2013
Q2
$21K Buy
+346
New +$20.8K 0.01% 344

Other funds holding CELG

Reilly Financial Advisors's CELG Position: Q4 2019 in Review

Reilly Financial Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,071 shares — an estimated $106K sold.

Reilly Financial Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $277K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Reilly Financial Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Reilly Financial Advisors sold 1,071 Celgene Corp shares in Q4 2019, an estimated $106K.
  • Reilly Financial Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Reilly Financial Advisors's Celgene Corp position peaked at $277K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Reilly Financial Advisors's 13F filing for Q4 2019, filed 16 Jan 2020.